Description: Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. The Company’s lead peptide product candidate is setmelanotide, a potent, first-in-class melanocortin-4 receptor, or MC4R, agonist for the treatment of rare genetic disorders of obesity. Setmelanotide serves as replacement therapy for the treatment of melanocortin-4, or MC4, pathway deficiencies. MC4 pathway deficiencies result in the disruption of satiety signals and energy homeostasis in the body, which, in turn, leads to intense feelings of hunger and to obesity. The Company also focused on obesity related to six single gene-related, or monogenic, MC4 pathway deficiencies pro-opiomelanocortin, or POMC, leptin receptor, or LepR, Bardet-Biedl syndrome, Alstrom syndrome, POMC heterozygous, and POMC epigenetic disorders.
Home Page: www.rhythmtx.com
RYTM Technical Analysis
222 Berkeley Street
Boston,
MA
02116
United States
Phone:
857 264 4280
Officers
Name | Title |
---|---|
Dr. David P. Meeker M.D. | Chairman, Pres & CEO |
Mr. Hunter C. Smith M.B.A. | CFO & Treasurer |
Mr. Joseph Shulman | Chief Technical Officer |
Mr. Yann Mazabraud | Exec. VP & Head of International |
Ms. Jennifer L. Chien | Exec. VP & Head of North America |
Mr. William T. Roberts | Chief Accounting Officer |
Mr. David Connolly | Head of Investor Relations & Corp. Communications |
Mr. Jim Flaherty | Sr. VP & Gen. Counsel |
Ms. Sarah Ryan | VP of Sales & Marketing |
Ms. Pamela J. Cramer | Chief HR Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 5.0137 |
Price-to-Sales TTM: | 95.689 |
IPO Date: | 2017-10-05 |
Fiscal Year End: | December |
Full Time Employees: | 140 |